Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methenamine Hippurate vs Trimethoprim for Recurrent UTI Prevention
NCT03077711Phase 4Completed
- Sponsor
- Endeavor Health
- Start
- Jun 2016
- Primary completion
- Jun 2019
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of methenamine hippurate in urinary tract infection (UTI) (2 arms), sponsored by Endeavor Health. Primary endpoints: Time to Subsequent Infection as Defined From Time of Treatment Initiation to Recurrence of UTI at 12 months, Recurrent UTI at 12 months and 1 more. Started Jun 2016; status: completed.
02
Drugs
methenamine hippurate
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT03077711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03077711.